The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma
Allergy
.
2022 Dec;77(12):3676-3679.
doi: 10.1111/all.15438.
Epub 2022 Jul 23.
Authors
Josh G Kim
1
,
Ai Zhang
1
,
Adriana M Rauseo
2
,
Charles W Goss
3
,
Philip A Mudd
4
,
Jane A O'Halloran
2
,
Leyao Wang
1
Affiliations
1
Division of Allergy and Immunology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
2
Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
3
Division of Biostatistics, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
4
Department of Emergency Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
PMID:
35837881
PMCID:
PMC9350136
DOI:
10.1111/all.15438
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
MeSH terms
Asthma* / diagnosis
COVID-19*
Humans
Microbiota*
Nasopharynx
Saliva
Grants and funding
P30 CA091842/CA/NCI NIH HHS/United States
R21 AI139649/AI/NIAID NIH HHS/United States
UL1 TR002345/TR/NCATS NIH HHS/United States
NH/NIH HHS/United States